http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13339634

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, N.I.H., Extramural|Research Support, U.S. Gov't, Non-P.H.S.
endingPage 7618
issn 1538-7445
0008-5472
issueIdentifier 19
pageRange 7612-7618
publicationName Cancer Research
startingPage 7612
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c7707d630afb025da14004d71a88773e
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_55c5bddd8b18b34c08263c5cd9750ed1
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ee4587986d4c489e3175992f71fd5f59
bibliographicCitation Wang X, Zhang W, Ishii T, Sozer S, Wang J, Xu M, Hoffman R. Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents. Cancer Res. 2009 Oct 01;69(19):7612–8. PMID: 19752087; PMCID: PMC3234420.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ba0d17528dd050a1698d96fe91055f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02981ca84aeb88bb35e6d7a8fd9b1b37
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da97e8bded8702313f11f9353275f66f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a2a0aad185748a11550ef533abe00c34
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66a0eff99d9e77db324961ba30647a70
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc4391cf53a23cdcb359644b4817e719
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_207c87914717455fbfd1feb4cec7c787
date 2009-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/0008-5472.can-09-1823
https://pubmed.ncbi.nlm.nih.gov/19752087
https://pubmed.ncbi.nlm.nih.gov/PMC3234420
isPartOf https://portal.issn.org/resource/ISSN/1538-7445
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2786
https://portal.issn.org/resource/ISSN/0008-5472
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Correction of the Abnormal Trafficking of Primary Myelofibrosis CD34+ Cells by Treatment with Chromatin-Modifying Agents
discusses http://id.nlm.nih.gov/mesh/M0002060
http://id.nlm.nih.gov/mesh/M0004370
http://id.nlm.nih.gov/mesh/M0519370
http://id.nlm.nih.gov/mesh/M0029275
http://id.nlm.nih.gov/mesh/M0028322
http://id.nlm.nih.gov/mesh/M0010739
http://id.nlm.nih.gov/mesh/M0062824
http://id.nlm.nih.gov/mesh/M0059711
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D006877Q000494
http://id.nlm.nih.gov/mesh/D002843Q000187
http://id.nlm.nih.gov/mesh/D001374Q000031
http://id.nlm.nih.gov/mesh/D055728Q000473
http://id.nlm.nih.gov/mesh/D055728Q000188
hasSubjectTerm http://id.nlm.nih.gov/mesh/D016513
http://id.nlm.nih.gov/mesh/D013154Q000473
http://id.nlm.nih.gov/mesh/D016688
http://id.nlm.nih.gov/mesh/D015536
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D055728Q000378
http://id.nlm.nih.gov/mesh/D000077209
http://id.nlm.nih.gov/mesh/D018952Q000096
http://id.nlm.nih.gov/mesh/D019718Q000096
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D001374Q000494
http://id.nlm.nih.gov/mesh/D001853Q000473
http://id.nlm.nih.gov/mesh/D000818
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_54e32599939667ce8030f6c1725ceac0
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8153
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f762fe2442e70fe54d540f3fd4225b55
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449435
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9876
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11133
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1d2c6279569a5e5473d9efe0530fd802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444732
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_034e8f4842428b1bd8db28af167d55d8

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128725069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129662076
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245921350

Total number of triples: 71.